印度在生物制造方面名列第二,在各种技术方面名列前五,并提出了关于创新、可持续性和创造就业的Bio-E3政策。 India ranks 2nd in biological manufacturing, top 5 in various technologies, and introduces Bio-E3 policy for innovation, sustainability, and job creation.
印度正在成为研究和生物技术方面的全球领先国家,首席科学顾问Ajay Sood列举了取得的重大进展。 India is emerging as a global leader in research and biotechnology, with significant advancements cited by Principal Scientific Advisor Ajay Sood. 该国目前在生物制造方面名列第二,并且根据ASPI报告,在各种技术方面名列前五位。 The country now ranks second in biological manufacturing and is listed among the top five nations in various technologies, according to an ASPI report. 新的Bio-E3政策旨在推动创新、可持续性和创造就业,同时促进利益攸关方之间的合作,利用新兴技术创造更绿色的未来。 The new Bio-E3 policy aims to drive innovation, sustainability, and job creation while fostering collaboration among stakeholders, leveraging emerging technologies for a greener future.